ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

VERU Veru Inc

1.52
0.03 (2.01%)
시간외 단일가
최종 업데이트: 21:50:38
15분 지연
기업명 주식 심볼 시장 주식 타입
Veru Inc VERU 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.03 2.01% 1.52 21:50:38
개장가 저가 고가 종가 전일 종가
1.49
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202421:30GLOBEVeru to Present at the GLP-1 Based Therapeutics Summit
01/05/202421:30GLOBEVeru to Report Fiscal 2024 Second Quarter Financial Results..
30/04/202421:30GLOBEVeru Enrolls First Patients in Phase 2b Clinical Trial of..
25/04/202421:30GLOBEVeru to Present at the American Association of Clinical..
02/04/202405:05GLOBEVeru Announces Date of 2024 Annual Meeting of Shareholders
23/03/202405:05GLOBEVeru Reschedules Annual Meeting of Shareholders
12/03/202421:00GLOBEVeru Announces the Appointment of Louis Aronne MD as Chief..
28/02/202409:15GLOBEVeru Announces Notification from Nasdaq Related to Delayed..
20/02/202422:30GLOBEVeru Announces New Scientific Advisory Board for its..
16/02/202406:49EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
16/02/202406:06EDGAR2Form 8-K - Current report
15/02/202406:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202421:00EDGAR2Form 8-K - Current report
08/02/202420:30GLOBEVeru Reports Fiscal 2024 First Quarter Financial Highlights
07/02/202406:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/02/202422:30GLOBEVeru Announces FDA Clearance of IND Application to Initiate..
31/01/202422:30GLOBEVeru to Present at the Oppenheimer 34th Annual Healthcare..
27/01/202406:06EDGAR2Form 8-K - Current report
26/01/202423:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/01/202423:00EDGAR2Form DEF 14A - Other definitive proxy statements
25/01/202422:30GLOBEVeru to Report Fiscal 2024 First Quarter Financial Results..
08/01/202422:30GLOBEVeru Submits IND Application to FDA for the Development of..
27/12/202306:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
19/12/202322:30GLOBEVeru to Host Investor Call on January 4th, 2024 to Discuss..
18/12/202323:01EDGAR2Form 8-K - Current report
16/12/202306:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/12/202323:00GLOBEVeru Announces Pricing of Public Offering of Common Stock
14/12/202306:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/12/202306:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/12/202306:04EDGAR2Form 8-K - Current report
14/12/202306:01GLOBEVeru Announces Proposed Public Offering of Common Stock
09/12/202306:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/12/202304:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
18/11/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202307:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202307:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202307:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202306:54EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
16/11/202306:50EDGAR2Form 8-K - Current report
04/10/202321:30GLOBEVeru Reports Muscle Data from 5 Clinical Studies of..
03/10/202306:23EDGAR2Form 8-K - Current report
29/09/202305:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/09/202321:30GLOBEVeru Reaches Agreement with FDA on New Phase 3 Clinical..
20/09/202321:30GLOBEVeru to Participate in Fireside Chat at the 2023 Cantor..
11/09/202320:00EDGAR2Form 8-K - Current report
11/09/202320:00GLOBEVeru Reports Clinical Data from the Discontinued ARTEST..
30/08/202321:30GLOBEVeru to Present at the H.C. Wainwright 25th Annual Global..
11/08/202301:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202320:00EDGAR2Form 8-K - Current report
10/08/202319:30GLOBEVeru Reports Fiscal 2023 Third Quarter Financial Results

최근 히스토리

Delayed Upgrade Clock